EIKN Reports $0 Revenue, -$12.3M Net Loss, +15% YoY Users to 45K
Eikon Therapeutics, Inc. Common Stock · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) · Now $10.84
0.0% in 1h after detection
Post-detection moves
1h
0.0%
1d
—
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS